title: [Action of avermectins on lymphoid leukemia P-388 cells in vitro].
abstract: Avermectins are final products in the fermentation process with Streptomyces avermitilis. They have parasitocidic activity and are used as the main substances of insectoacaronematocides. The study of the activity of the natural avermectin complex (aversectin C) and separate avermectins A1, A2, B1 and B2 in the cell culture of lymphoid leukemia P-388 showed that within the concentrations of 0.1 to 1.0 microgram/ml aversectin C inhibited the growth of the tumor cells and induced their death. The inhibition was due to blocking the cell mitosis. The cell death was accompanied by internucleosomal degradation of the DNA nuclei i.e. the death was of the apoptosis type. The sensitivity of the cells to aversectin C was directly proportional to their initial proliferative activity. As for the separate avermectins only avermectin A1 had the cytotoxic activity within the concentrations used, avermectin A2 had the cytostatic activity and avermectins B1 showed no activity under the experimental conditions.
authors.affiliation: Farmbiomed Research Centre of Biology, Moscow.
authors.forename: V A
authors.initials: VA
authors.lastname: Mosin
authors.forename: E B
authors.initials: EB
authors.lastname: Krugliak
authors.forename: T S
authors.initials: TS
authors.lastname: Sterlina
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Korystov
authors.forename: V V
authors.initials: VV
authors.lastname: Shaposhnikova
authors.forename: L N
authors.initials: LN
authors.lastname: Kublik
authors.forename: M Kh
authors.initials: MKh
authors.lastname: Levitman
authors.forename: A V
authors.initials: AV
authors.lastname: Viktorov
authors.forename: V A
authors.initials: VA
authors.lastname: Driniaev
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000977:Antiparasitic Agents / Q000627:therapeutic use*; D004354:Drug Screening Assays, Antitumor; D007306:Insecticides / Q000627:therapeutic use*; D007559:Ivermectin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D013302:Streptomyces / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D000977:Antiparasitic Agents; D007306:Insecticides; D007559:Ivermectin; C019264:avermectin
vernacular_title: Deĭstvie avermektinov na kletki limfoleĭkoza P-388 in vitro.